Bicycle Therapeutics plc - American Depositary Shares — Cash Flow (NASDAQ:BCYC) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -17.79 M-14.79 M-86.11 M-60.63 M-164.72 M-249.68 M -229.23 M Cash from investing activities -1.2 M-2.03 M-18.99 M-2.93 M-1.24 M-2.35 M -2.46 M Cash from financing activities 62.84 M320.73 M6.69 M250.03 M519.75 M-131 K -144 K Free cash flow -17.79 M-14.79 M-86.11 M-60.63 M-164.72 M-249.68 M -229.23 M

News

Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?

Bicycle Therapeutics: Trading Below Cash Amid Multiple Uncertainties (NASDAQ:BCYC)

Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Morgan Stanley reiterates Bicycle Therapeutics stock rating on program shift

Bicycle Therapeutics earnings beat by $0.65, revenue topped estimates

Seres names Richard Kender as executive chair and interim CEO

Bicycle Therapeutics announces leadership changes for next phase

Oppenheimer reiterates Outperform rating on Bicycle Therapeutics stock

Bicycle Therapeutics stock rating reiterated at Market Outperform by Citizens

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Truist Securities initiates coverage on Bicycle Therapeutics stock with Hold rating